STAT
DECEMBER 29, 2023
It’s time to take stock of the year that was in health and science: the meteoric rise of weight loss drugs , the approval of the first CRISPR-based therapy , the continuing effects of abortion access restrictions after the Dobbs decision, and much more. Below is our annual list of stories that STAT staffers loved, and wish that they had written.
pharmaphorum
DECEMBER 29, 2023
Navigating transplant networks: Ensuring equitable access and improving outcomes for highly sensitised kidney transplant patients Mike.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 29, 2023
The U.S. drug crisis is as bad as it’s ever been, and there are few signs things are getting better. About 110,000 people died of drug overdoses in 2023, about the same as in previous years. Fentanyl, the powerful synthetic opioid that now dominates the illicit drug market, remained the main culprit. Xylazine, the veterinary sedative known as “tranq,” only became more common.
pharmaphorum
DECEMBER 29, 2023
Eisai and Oita University have developed a machine learning-powered wearable that can predict whether someone is at risk of developing Alzheimer’s disease
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
DECEMBER 29, 2023
My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but since he was 19 months old, he has worked with our entire family to manage his anaphylactic food allergies, asthma, and eosinophilic esophagitis. We are not alone.
Pharmaceutical Technology
DECEMBER 29, 2023
FDA warns that levetiracetam and clobazam can cause DRESS, a rare hypersensitivity reaction which can be life threatening.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
DECEMBER 29, 2023
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing environment, continuous learning is key. Therefore, Express Pharma is launching “Regulatory Watch” a series of Master Classes led by experts and thought leaders to empower you with the knowledge and insights needed to navigate the ever-changing regulatory landscape successfully.
Pharmaceutical Technology
DECEMBER 29, 2023
Enveric Biosciences has selected EB-003 as its lead drug candidate from its EVM301 series for difficult-to-treat mental health disorders.
Express Pharma
DECEMBER 29, 2023
Indian Immunologicals Limited (IIL) has started construction of its new greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicaemia Vaccine (FMD+HS-Vac) in Hyderabad’s Genome valley. This unit will have a BSL3 facility for the manufacture of Drug substances and a Fill-Finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine.
World Pharma News
DECEMBER 29, 2023
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat surfaces or require specificity for particular protein homologs. Typically, larger biologics that can target these proteins demand injection, limiting patient convenience and accessibility.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
DECEMBER 29, 2023
Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.
pharmaphorum
DECEMBER 29, 2023
In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.
Drug Patent Watch
DECEMBER 29, 2023
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting… The post New patent expiration for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Business Review
DECEMBER 29, 2023
Received through the foundation’s Inflammatory Bowel Disease (IBD) Ventures programme, this payment is part of a priorly disclosed grant under research programme agreement with Giiant Pharma to support the development of treatments for moderate-to-severe ulcerative colitis (UC). The latest payment is received by Giiant Pharma, the company’s co-development partner.
Drug Patent Watch
DECEMBER 29, 2023
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from two suppliers. There… The post New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT appeared first on DrugPatentWatch - Make Better Decisions.
The Thyroid Pharmacist
DECEMBER 29, 2023
Wow… do the years just fly by! I can’t believe that it’s been over 10 years since I started the thyroidpharmacist.com blog in 2013, and now 2023 is almost over. Around this time of year, I tend to be very introspective. I was visiting with my family and my mom commented about how quiet I have been… but I love this time of year… the end of the year is always a perfect opportunity to reflect, let go of the past, dream, and plan for the future.
Drug Patent Watch
DECEMBER 29, 2023
Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are… The post New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP appeared first on DrugPatentWatch - Make Better Decisions.
Community Pharmacy
DECEMBER 29, 2023
More than half of all Americans say they would like to lose weight, but making this goal a reality can be an intimidating task to take on alone. As we head into the New Year, there’s no better time than now to implement change in your routine and habits that can lead to real, lasting weight loss. Over the years Community Pharmacy has developed our Weight Loss Protocol , a system that has proven to work, whether you are looking to trim a few pounds or lose—and keep off—substantial weight.
Drug Patent Watch
DECEMBER 29, 2023
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are six… The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 29, 2023
To learn more, Deep Dive editor Eloise McLennan sat down with Calculus Capital’s investment director, Liz Klein, to discuss the dynamic world where capital meets compassion.
PharmaTech
DECEMBER 29, 2023
Through Syena, its oncology-focused product company, Replay will develop and manufacture T-cell receptor and natural killer cell therapies with the NIH and Miltenyi Biotec.
Pharmaceutical Commerce
DECEMBER 29, 2023
Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.
PharmaTech
DECEMBER 29, 2023
Clinician-Scientists are vital innovation spark plugs, accounting for 40% of Nobel awards in Physiology or Medicine, and two thirds of Big Pharma CSOs.
RX Note
DECEMBER 29, 2023
Introduction At times, you may encounter useful mobile applications that are not available in your country, such as BNF Publications. However, do not feel disappointed. iOS Devices To install apps not available in your country, you can either Option 1: Create a new Apple ID with a different country or region Sign out of your current Apple ID in the App Store.
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read pediatrics-related articles on Pharmacy Times in 2023.
Drug Patent Watch
DECEMBER 29, 2023
This chart shows the pharmaceutical companies with the most gel dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gel dosed drugs… The post Which pharmaceutical companies have the most gel dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read oncology-related articles on Pharmacy Times in 2023.
RX Note
DECEMBER 29, 2023
Introduction The Qualifying Examination to Practice Pharmacy is pre-requisite for pharmacist registration with the Pharmacy Board of Malaysia (PBM). It is held 3 times a year to examine candidates' knowledge and ability to apply Malaysia laws regulating the sale and supply of medicinal products from pharmacies. Category of Applicants The following groups of applicants are eligible to sit for the examination: Pharmacy graduates who are the citizens of Malaysia and wish to register as Provisionall
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read health systems-related articles on Pharmacy Times in 2023.
Express Pharma
DECEMBER 29, 2023
Venus Remedies has secured marketing authorisation for docetaxel from Israel and cytarabine from Colombia. While docetaxel, an antineoplastic agent, is beneficial in the treatment of breast, prostate, head, neck and non-small cell lung cancer, cytarabine is useful in acute non-lymphocytic leukaemia, acute lymphocytic leukaemia and chronic myelocytic leukaemia.
Expert insights. Personalized for you.
362 
Let's personalize your content